Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1)

被引:21
|
作者
Abd El Motteleb, Dalia M. [1 ]
Ibrahim, Islam A. A. E. -H. [2 ]
Elshazly, Shimaa M. [2 ]
机构
[1] Zagazig Univ, Clin Pharmacol Dept, Fac Med, Zagazig, Egypt
[2] Zagazig Univ, Fac Pharm, Pharmacol & Toxicol Dept, Zagazig 44519, Egypt
关键词
Sildenafil; Hepatic fibrosis; SIRT1; Inflammation; Oxidative stress; LIVER FIBROSIS; ERECTILE DYSFUNCTION; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; IN-VITRO; ACTIVATION; INJURY; DEACETYLASE; RECEPTOR; TRANSCRIPTION;
D O I
10.1016/j.taap.2017.09.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hepatic fibrosis is a potential health problem that may end with life-threatening cirrhosis and primary liver cancer. Recent studies point out to the protective effects of silent information regulator) (SIRT1), against different models of organs fibrosis. This work aimed to investigate the possible protective effect of sildenafil (SIRT1 activator) against hepatic fibrosis induced by bile duct ligation (BDL). Firstly, three different doses of sildenafil (5, 10, 20 mg/kg/day) were investigated; to detect the most protective one against BDL induced liver dysfunction and hepatic fibrosis. The most protective dose is then used; to study its effect on BDL induced SIRT1 downregulation, imbalance of oxidant/antioxidant status, increased inflammatory cytokines and fibrosis. Sildenafil (20 mg/kg/day) was the most protective one, it caused upregulation of SIRT1, reduction of hepatic malondialdehyde (MDA) content, increase in expression of nuclear factor erythroid 2-related factor 2 (Nrf2), hemeoxygenease (HO)-1, reduced glutathione (GSH) content and superoxide dismutase (SOD) activity. Hepatic content of tumor necrosis factor-alpha (TNF-alpha) and nuclear factor kappa B (NF kappa B) expression & content displayed significant reductions with sildenafil treatment, Furthermore, sildenafil caused marked reductions of transforming growth factor (TGF)-beta content, expression of plasminogen activator inhibitor-1 (PAI-1), matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1 (TIMP-1), alpha-smooth muscle actin (alpha-SMA), fibronectin, collagen I (alpha 1) and hydroxyproline content. However, sildenafil protective effects were significantly reduced by co-administration of EX527 (SIRT1 inhibitor). Our work showed, for the first time that, sildenafil has promising protective effects against BDL induced liver dysfunction and hepatic fibrosis. These effects may be, in part, mediated by up regulation of SIRT1.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 50 条
  • [21] Preventative and therapeutic effects of perindopril on hepatic fibrosis induced by bile duct ligation in rats
    Ueki, Masaru
    Koda, Masahiko
    Matono, Tomomitsu
    Sugihara, Takaaki
    Maeda, Kazunori
    Murawaki, Yoshikazu
    MOLECULAR MEDICINE REPORTS, 2009, 2 (05) : 857 - 864
  • [22] The Efficacy of Antioxidative Therapy in Hepatic Fibrosis Induced Experimentally by Bile Duct Ligation in Rats
    Al-Hayani, Abdulmonem
    JOURNAL OF ANIMAL AND VETERINARY ADVANCES, 2011, 10 (06): : 764 - 773
  • [23] The role of PPARγ in bile duct ligation-induced hepatic injury in rats
    Kitagawa, Tomomi
    Yokoyama, Yukihiro
    Kawai, Toru
    Kawai, Kiyotaka
    Watanabe, Katsutaka
    Nagino, Masato
    HEPATOLOGY, 2007, 46 (04) : 339A - 339A
  • [24] Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion
    Wu, Yuting
    Liu, Xuejiao
    Zhou, Qun
    Huang, Cheng
    Meng, Xiaoming
    Xu, Fengyun
    Li, Jun
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2015, 289 (02) : 163 - 176
  • [25] Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis
    Song, Ming
    Song, Zhenyuan
    Barve, Shirish
    Zhang, Jingwen
    Chen, Theresa
    Liu, Marcia
    Arteel, Gavin E.
    Brewer, George J.
    McClain, Craig J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (02): : 409 - 416
  • [26] Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine
    Chen, Kuan-Chung
    Jian, Yi-Ru
    Sun, Mao-Feng
    Chang, Tung-Ti
    Lee, Cheng-Chun
    Chen, Calvin Yu-Chian
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2013, 31 (11): : 1207 - 1218
  • [27] Synthesis of indole inhibitors of silent information regulator 1 (SIRT1), and their evaluation as cytotoxic agents
    Laaroussi, Hanna
    Ding, Ying
    Teng, Yuou
    Deschamps, Patrick
    Vidal, Michel
    Yu, Peng
    Broussy, Sylvain
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 202
  • [28] Geniposide protects against pathological cardiac fibrosis in vivo and in vitro: the role of SIRT1 activation
    Li, Ning
    Tang, Qizhu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C83 - C83
  • [29] Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats
    Ueki, Masaru
    Koda, Masahiko
    Yamamoto, Satoru
    Matsunaga, Yoshiko
    Murawaki, Yoshikazu
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (10) : 996 - 1004
  • [30] Simvastatin preconditioning confers neuroprotection against hypoxia-ischemia induced brain damage in neonatal rats via autophagy and silent information regulator 1 (SIRT1) activation
    Carloni, Silvia
    Balduini, Walter
    EXPERIMENTAL NEUROLOGY, 2020, 324